Bunkerhill MAC vs Cleerly LABS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by Cleerly

AI Verdict

Bunkerhill MAC specializes in detecting and quantifying mitral annular calcification (MAC) on routine CT scans for early cardiovascular risk identification. In contrast, Cleerly LABS provides comprehensive AI-powered analysis of coronary CT angiography (CCTA) to characterize atherosclerosis and stenosis for personalized heart disease management. While both are cardiovascular AI tools utilizing CT imaging, they focus on distinct anatomical areas and require different types of CT scans, making them complementary rather than direct competitors.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if you need to leverage existing, routine chest CT scans to identify patients at increased cardiovascular risk due to mitral annular calcification (MAC). This tool is ideal for integrating early risk identification into automated workflows and care coordination within a generative AI platform, without requiring dedicated cardiac imaging.

View Bunkerhill MAC →

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely detect, quantify, and characterize atherosclerosis and stenosis. This tool is best suited for personalized heart disease management, tracking disease progression over time, and providing detailed insights for patients undergoing dedicated cardiac imaging for coronary artery disease.

View Cleerly LABS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill MAC Cleerly LABS
Pricing Contact for pricing Per analysis
Deployment Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform. Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill MAC

Bunkerhill MAC integrates seamlessly with existing EHRs and clinical systems via the Carebricks platform, which is designed to automate workflows and clinical reasoning. This deep integration suggests a more embedded and less disruptive user experience within existing healthcare IT environments compared to Cleerly LABS' web-based application with an on-site proxy.

Clinical Value

Cleerly LABS

Cleerly LABS offers a comprehensive analysis of coronary CT angiography (CCTA) for detecting, quantifying, and characterizing atherosclerosis and stenosis, including plaque volume and type, and ischemia detection with an additional module. This provides a more detailed and personalized assessment of coronary artery disease compared to Bunkerhill MAC's focus on mitral annular calcification from routine CT scans.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing details, including a per-analysis cost and information on potential insurance coverage and out-of-pocket expenses. In contrast, Bunkerhill MAC's pricing is listed as 'contact for pricing,' making it impossible to assess its value proposition.

Enterprise Readiness

Cleerly LABS

Cleerly LABS explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA). While Bunkerhill MAC states these are 'likely,' the explicit confirmation from Cleerly LABS provides greater assurance for enterprise adoption and compliance requirements.

Innovation

Bunkerhill MAC

Bunkerhill MAC leverages 'Generative AI for clinical reasoning and action' and integrates with the broader Carebricks platform to automate follow-up and care coordination, moving beyond just detection to proactive clinical action. Its ability to analyze routine, non-gated CT scans for opportunistic screening also represents an innovative application of AI.

Support & Docs

Tie

Neither the provided structured facts nor web searches yielded specific, detailed information regarding dedicated support portals, extensive documentation libraries, or service level agreements for either Bunkerhill MAC or Cleerly LABS. Both companies offer general contact methods for support inquiries.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill MAC Cleerly LABS
Name Bunkerhill MAC Cleerly LABS
Company Bunkerhill Health Cleerly
Primary Imaging Modality/Focus Routine, non-gated chest CT scans for Mitral Annular Calcification (MAC). Coronary CT angiography (CCTA) for atherosclerosis and stenosis.
Key Detection/Quantification AI-powered detection and quantification of Mitral Annular Calcification (MAC). AI-powered CCTA image analysis; comprehensive coronary plaque assessment (volume, type); stenosis detection and quantification; ischemia detection (with Cleerly ISCHEMIA module).
Integration Integrates with existing EHRs and clinical systems via Carebricks platform. Integration with PACS, RIS, EHR via Cleerly Proxy.

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Cleerly LABS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC analyzes routine, non-gated chest CT scans to detect and quantify mitral annular calcification (MAC), aiding in early cardiovascular risk identification. Cleerly LABS analyzes coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, supporting personalized heart disease management.
Bunkerhill MAC focuses on identifying patients at increased cardiovascular risk by detecting MAC on routine CTs and integrates with the Carebricks platform for clinical reasoning and care coordination. Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection, and personalized heart disease risk assessment from CCTA, with capabilities to track disease progression over time.
Bunkerhill MAC requires contacting Bunkerhill Health for pricing information. Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at $750 (discounted), in addition to the separate cost of the CCTA scan, which can result in total out-of-pocket costs often ranging from $1000-$1500.
Bunkerhill MAC supports automated workflows for follow-up and care coordination and integrates with the Carebricks generative AI platform for clinical reasoning and action. Cleerly LABS enables tracking disease progression over time and provides personalized heart disease risk assessment to aid in personalized heart disease management.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.